GlassScriptPhysician profile
Michael T Kolinski
NPI 1184722555
$24,598.82
in general payments reported to CMS, 2019-2025
46 companies · $5,143 in 2025
The $5,143 reported for 2025 was more than what 97% of Neuromusculoskeletal Medicine & Omm providers received nationally (typical 2025 total: $119).
See the full distribution for Neuromusculoskeletal Medicine & OMM
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,522 · 2020: $863 · 2021: $1,263 · 2022: $5,803 · 2023: $5,043 · 2024: $3,962 · 2025: $5,143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $2,849 · Education: $40.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,258.69 |
| Travel and Lodging | $2,849.36 |
| Education | $40.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,041.67 | 2019-2025 | Eterna, Proclaim, Octrode |
| Saluda Medical Americas, INC. | $3,381.64 | 2022-2025 | Evoke Scs, Evoke |
| Medtronic, INC. | $2,393.44 | 2022-2025 | Intellis Adaptivestim, Synchromedii, Interstim |
| Abbvie INC. | $1,652.71 | 2021-2025 | |
| Globus Medical, INC. | $1,620.95 | 2025 | Senza |
| Spinal Simplicity, LLC | $1,521.58 | 2022 | |
| Nevro Corp. | $1,374.65 | 2020-2024 | Senza |
| Medtronic USA, INC. | $1,327.50 | 2019-2020 | |
| Painteq LLC | $992.02 | 2023-2024 | Painteq |
| Boston Scientific Corporation | $656.48 | 2020-2025 | General - Pain Management |
| Pfizer INC. | $513.65 | 2019-2025 | |
| Foundation Fusion Solutions, LLC | $497.28 | 2022 | |
| Curonix LLC | $472.92 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Lilly USA, LLC | $399.16 | 2019-2022 | |
| Si-Bone, INC. | $373.67 | 2021-2025 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kolinski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.